CX3CL1 and pancreatic neoplasm: Studies on pancreatic cancer cells also showed that CX3CL1 is chemotactic for pancreatic ductal adenocarcinoma cells, and cell migration was decreased when cells were treated with siRNA against CX3CR1 96.